Why has Pepcid chewables been pulled from all store shelves?

Johnson & Johnson • Merck Consumer Pharmaceuticals, Co. (JJMCP) is initiating a voluntary recall of one lot of PEPCID® COMPLETE®, lot number BEF062, and one lot of ORIGINAL STRENGTH PEPCID® AC®, lot number BFF010, from the wholesaler and retailer level. This is not a consumer level recall and the risk of a serious adverse health consequence is remote. The recall is being initiated because the potential exists for a small number of bottles within these two lots to have been punctured during the packaging process. The puncture was discovered as part of the company’s quality control processes.

JJMCP is committed to providing high quality products and we have provided our wholesalers and retailers with information about this recall.

Expand this post...

Consumers with general questions should call our Consumer Care Center at 1-800-755-4008 (available Monday-Friday 8 a.m. to 8 p.m. Eastern Time). Consumers who have health concerns should contact their healthcare provider. Any adverse reactions may also be reported to the FDA’s MedWatch Program by fax at 1-800-FDA-0178, by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov/safety/medwatch/default.htm.

JJMCP is a U.S.-based 50/50 joint venture formed to research, develop, manufacture, market and sell consumer healthcare products in the United States, including Infants’ MYLICON®, MYLANTA®, PEPCID® COMPLETE® and PEPCID® AC®.